LQDA

Liquidia Corp

Nasdaq · Pharmaceutical Preparations · Inc. DE · CIK 0001819576
$71.23 -0.56% $6.3B
Insider Selling Cluster (8 insiders)High Impact Filing (8/10)11 New Institutional Positions8 Institutional Exits
Vol
Market Cap$6.3B
Cap SizeMid Cap
Inst. Holders50 funds
Inst. Value$1.3B
Inst. Activity11 buys / 8 sells
Insider Activity1B / 46S
Insider Net $-$50.5M
Reddit Sentiment50° Neutral
SEC Reports20
Press Releases1
Exchange Nasdaq·Sector Pharmaceutical Preparations·Inc. DE·CIK 0001819576·Prev Close $71.63

Recent Activity

Jun 11, 2026 SEC
Six major passive asset managers increased their Liquidia Corp (LQDA) positions in Q3 2025, with aggregate holdings jump
INST-CLUSTER — Impact 5/10
Jun 11, 2026 Insider
Bloch Stephen M sold 1,476 shares
Director @ $66.40 ($98.0K)
Jun 11, 2026 short_volume
Short Volume: LQDA — 60.4% short (0.8M / 1.3M)
Short: 801,858 | Exempt: 774 | TRF Vol: 1,326,871 | Short Ratio: 60.4% | Off-exchange volume (dark p
Jun 10, 2026 SEC
Canaan VIII LP, a director and venture investor, filed a Form 144 to sell 200,000 shares of Liquidia Corp (LQDA) worth a
144 — Impact 5/10
Jun 10, 2026 Insider
Bloch Stephen M sold 14,416 shares
Director @ $64.48 ($929.6K)
Jun 9, 2026 Insider
Bloch Stephen M sold 64,500 shares
Director @ $64.27 ($4.1M)
Jun 8, 2026 SEC
Four Liquidia Corp insiders, all directors and one CHRO, sold a total of $4.26M in open-market transactions over a 7-day
CLUSTER — Impact 3/10
Inst.
FMR LLC — ADD
582,200 shares ($22.0M)

Price Targets

Historical data — last covering-analyst action Oct 2024. No current recommendation available.
$66.13 (Oct 2024)
Current $71.23 Low $59.00 Median $66.00 High $75.00 8 analysts
$59.00 $75.00

Analyst Ratings

Historical distribution93% buy · 14 analysts · last covering-analyst action Oct 2024
6Strong Buy
7Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
DateFirmActionRating
Oct 16, 2024 Scotiabank INITIATE Sector Outperform
Oct 3, 2024 LifeSci Capital INITIATE Outperform
Aug 23, 2024 HC Wainwright & Co. REITERATE Buy → Buy
Aug 22, 2024 Needham REITERATE Buy → Buy
Aug 20, 2024 BTIG MAINTAIN Buy → Buy

Earnings Estimates

PeriodEPS Est.RangeGrowth#
Current Q $0.84 ▲ +57.7% $0.77 — $0.97 271% YoY 5
Next Q $0.97 ▲ +32.3% $0.41 — $1.26 2515% YoY 5
Current FY $3.48 ▲ +35.0% $2.36 — $4.09 535% YoY 5
Next FY $5.57 ▲ +6.4% $4.00 — $7.16 60% YoY 5

Top Institutional Holders

FundValueMove
FARALLON CAPITAL MANAGEMENT LLC$326.7MEXIT
BlackRock, Inc.$207.2M
VANGUARD CAPITAL MANAGEMENT LLC$110.5M
BANK OF AMERICA CORP$86.3MDOUBLED
STATE STREET CORP$71.0M

Recent Insider Trades

DateInsiderTypeValue
Jun 11, 2026Bloch StephenSELL$98.0K
Jun 10, 2026Bloch StephenSELL$929.6K
Jun 9, 2026Bloch StephenSELL$4.1M
Jun 8, 2026Khindri SanjeevSELL$270.6K
Jun 8, 2026Bloch StephenSELL$6.9M

Reddit Sentiment

50°
Neutral
Bearish Neutral Bullish
1 mentions 0 bullish 0 bearish
50 institutional holders with $1.3B total value (33,906,633 shares) as of 2026-Q1. Top holders: FARALLON, BlackRock,, VANGUARD. Net buying activity: 11 institutions added/increased vs 8 reduced.

Top Institutional Holders — 2026-Q1

#FundSharesValue% of TrackedLast Move
1FARALLON CAPITAL MANAGEMENT LLC8,656,038$326.7M25.5%EXIT -100.0%
2BlackRock, Inc.5,489,144$207.2M16.2%
3VANGUARD CAPITAL MANAGEMENT LLC2,926,945$110.5M8.6%
4BANK OF AMERICA CORP /DE/2,287,792$86.3M6.7%DOUBLED +151.8%
5STATE STREET CORP1,881,599$71.0M5.6%
6CITADEL ADVISORS LLC1,493,300$56.4M4.4%
7SUSQUEHANNA INTERNATIONAL GROUP, LLP1,001,081$37.8M3.0%
8D. E. Shaw & Co., Inc.873,065$32.9M2.6%DOUBLED +916.1%
9GOLDMAN SACHS GROUP INC811,990$30.6M2.4%
10VANGUARD PORTFOLIO MANAGEMENT LLC632,625$23.9M1.9%
11FMR LLC582,200$22.0M1.7%ADD +53.9%
12TWO SIGMA INVESTMENTS, LP563,233$21.3M1.7%TRIM -41.9%
13CHARLES SCHWAB INVESTMENT MANAGEMENT INC557,200$21.0M1.6%ADD +29.4%
14Invesco Ltd.481,446$18.2M1.4%DOUBLED +428.3%
15VANGUARD FIDUCIARY TRUST CO472,273$17.8M1.4%
16FEDERATED HERMES, INC.438,767$16.6M1.3%ADD +51.7%
17Trexquant Investment LP409,259$15.4M1.2%ADD +46.6%
18SUSQUEHANNA INTERNATIONAL GROUP, LLP377,600$14.3M1.1%
19MORGAN STANLEY344,671$13.0M1.0%TRIM -27.2%
20MARSHALL WACE, LLP289,439$10.9M0.9%ADD +98.7%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
FMR LLCADD378,344582,200+53.9%$22.0M2026-Q1
Trexquant Investment LPADD279,138409,259+46.6%$15.4M2026-Q1
MORGAN STANLEYTRIM473,532344,671-27.2%$13.0M2026-Q1
MARSHALL WACE, LLPADD145,639289,439+98.7%$10.9M2026-Q1
DEUTSCHE BANK AG\TRIM187,814137,652-26.7%$5.2M2026-Q1
VICTORY CAPITAL MANAGEMENT INCDOUBLED7,98498,357+1131.9%$3.7M2026-Q1
PRUDENTIAL FINANCIAL INCNEAR_EXIT459,76680,280-82.5%$3.0M2026-Q1
VOLORIDGE INVESTMENT MANAGEMENT, LLCNEAR_EXIT532,42575,602-85.8%$2.9M2026-Q1
BALYASNY ASSET MANAGEMENT L.P.ADD57,67072,895+26.4%$2.8M2026-Q1
MANUFACTURERS LIFE INSURANCE COMPANY, THEADD35,67358,265+63.3%$2.2M2026-Q1
TUDOR INVESTMENT CORP ET ALTRIM56,74140,263-29.0%$1.5M2026-Q1
SEI INVESTMENTS CODOUBLED8,77635,655+306.3%$1.3M2026-Q1
Mariner, LLCTRIM49,75222,791-54.2%$860.5K2026-Q1
RENAISSANCE TECHNOLOGIES LLCNEAR_EXIT206,8538,100-96.1%$305.7K2026-Q1
NISA INVESTMENT ADVISORS, LLCDOUBLED8902,103+136.3%$79.4K2026-Q1
BNP Paribas Asset Management Holding S.A.ADD8631,144+32.6%$43.2K2026-Q1
PRICE T ROWE ASSOCIATES INC /MD/DOUBLED37,111953,151+2468.4%$36.0K2026-Q1
CWM, LLCADD341536+57.2%$20.2K2026-Q1
HRT FINANCIAL LPTRIM168,17686,687-48.5%$3.3K2026-Q1
BANK OF AMERICA CORP /DE/DOUBLED765,3461,927,420+151.8%$66.5M2025-Q4
FEDERATED HERMES, INC.ADD320,597486,333+51.7%$16.8M2025-Q4
MORGAN STANLEYTRIM1,006,707473,532-53.0%$16.3M2025-Q4
PRUDENTIAL FINANCIAL INCDOUBLED23,555459,766+1851.9%$15.9M2025-Q4
Invesco Ltd.DOUBLED79,612420,621+428.3%$14.5M2025-Q4
FMR LLCTRIM907,679378,344-58.3%$13.0M2025-Q4
13 unique insiders with 50 transactions. Net insider value: -$50.5M ($317.9K bought, $50.9M sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
Jun 11, 2026Bloch Stephen MDirectorSELL1,476$66.40$98.0K
Jun 10, 2026Bloch Stephen MDirectorSELL14,416$64.48$929.6K
Jun 9, 2026Bloch Stephen MDirectorSELL64,500$64.27$4.1M
Jun 8, 2026Khindri SanjeevChief Development OfficerSELL4,134$65.46$270.6K
Jun 8, 2026Bloch Stephen MDirectorSELL106,310$64.49$6.9M
Jun 5, 2026Bloch Stephen MDirectorSELL2,064$64.14$132.4K
Jun 4, 2026Manning Paul BDirectorSELL11,513$63.13$726.8K
Jun 4, 2026Bloch Stephen MDirectorSELL46,108$64.47$3.0M
Jun 3, 2026KIRSCH ARTHUR SDirectorSELL10,000$54.80$548.0K
Jun 2, 2026KIRSCH ARTHUR SDirectorSELL5,000$56.00$280.0K
Jun 1, 2026KIRSCH ARTHUR SDirectorSELL15,000$60.22$903.3K
Jun 1, 2026Krepp SarahChief Human Resource OfficerSELL276$60.87$16.8K
May 27, 2026JEFFS ROGERChief Executive OfficerSELL6,428$62.18$399.7K
May 26, 2026JEFFS ROGERChief Executive OfficerSELL25,000$60.38$1.5M
May 22, 2026JEFFS ROGERChief Executive OfficerSELL25,000$61.52$1.5M
May 21, 2026SINGH RAMANDirectorSELL29,494$60.13$1.8M
May 21, 2026JEFFS ROGERChief Executive OfficerSELL25,000$61.13$1.5M
May 21, 2026SINGH RAMANDirectorEXERCISE19,444$8.63$167.8K
May 20, 2026JEFFS ROGERChief Executive OfficerSELL25,000$61.30$1.5M
May 19, 2026JEFFS ROGERChief Executive OfficerSELL25,000$58.65$1.5M
May 19, 2026Caligan Partners LPDirectorBUY5,300$59.98$317.9K
May 19, 2026Caligan Partners LPDirectorSELL5,300$59.98$317.9K
May 18, 2026JEFFS ROGERChief Executive OfficerSELL25,000$56.77$1.4M
May 15, 2026JEFFS ROGERChief Executive OfficerSELL25,000$57.04$1.4M
May 14, 2026JEFFS ROGERChief Executive OfficerSELL25,000$58.62$1.5M
May 13, 2026JEFFS ROGERChief Executive OfficerSELL25,000$56.29$1.4M
May 12, 2026JEFFS ROGERChief Executive OfficerSELL25,000$54.04$1.4M
May 11, 2026JEFFS ROGERChief Executive OfficerSELL25,000$41.50$1.0M
May 11, 2026Bloch Stephen MDirectorSELL75,801$48.61$3.7M
May 8, 2026JEFFS ROGERChief Executive OfficerSELL25,000$42.14$1.1M
May 7, 2026JEFFS ROGERChief Executive OfficerSELL25,000$42.09$1.1M
May 6, 2026JEFFS ROGERChief Executive OfficerSELL25,000$40.78$1.0M
May 5, 2026JEFFS ROGERChief Executive OfficerSELL25,000$40.10$1.0M
Apr 27, 2026Adair JasonChief Business OfficerSELL688$41.65$28.7K
Apr 27, 2026Boyle DanaChief Accounting OfficerSELL1,576$37.78$59.5K
Apr 17, 2026JEFFS ROGERChief Executive OfficerSELL18,839$40.60$765.0K
Apr 16, 2026JEFFS ROGERChief Executive OfficerSELL25,000$40.31$1.0M
Apr 15, 2026Kaseta MichaelCFO and COOSELL9,044$40.14$363.0K
Apr 15, 2026Kaseta MichaelCFO and COOEXERCISE86,971$2.79$242.6K
Apr 15, 2026JEFFS ROGERChief Executive OfficerSELL25,000$40.14$1.0M
Apr 14, 2026Kaseta MichaelCFO and COOEXERCISE3,000$2.79$8.4K
Apr 14, 2026Kaseta MichaelCFO and COOSELL3,000$40.00$120.0K
Apr 14, 2026JEFFS ROGERChief Executive OfficerSELL3,300$40.00$132.0K
Apr 13, 2026JEFFS ROGERChief Executive OfficerSELL32,744$38.37$1.3M
Apr 13, 2026Schundler RussellGeneral CounselSELL13,692$38.37$525.4K
Apr 13, 2026Krepp SarahChief Human Resource OfficerSELL4,557$38.37$174.9K
Apr 13, 2026Saggar RajeevChief Medical OfficerSELL9,220$38.37$353.8K
Apr 13, 2026Kaseta MichaelCFO and COOSELL18,958$38.37$727.4K
Apr 13, 2026Boyle DanaChief Accounting OfficerSELL5,101$38.37$195.7K
Apr 13, 2026Adair JasonChief Business OfficerSELL7,301$38.37$280.1K
20 SEC filing reports analyzed. Sentiment: 3 bullish, 7 bearish, 1 mixed, 9 neutral. Avg impact: 4.8/10.
BULLISH INST-CLUSTER 5/10
Six major passive asset managers increased their Liquidia Corp (LQDA) positions in Q3 2025, with agg
Jun 11, 2026
BEARISH 144 5/10
Canaan VIII LP, a director and venture investor, filed a Form 144 to sell 200,000 shares of Liquidia
Jun 10, 2026
NEUTRAL CLUSTER 3/10
Four Liquidia Corp insiders, all directors and one CHRO, sold a total of $4.26M in open-market trans
Jun 8, 2026
NEUTRAL CLUSTER, 8-K 5/10
LQDA has been selected for addition to the S&P SmallCap 600 Index, effective prior to the opening of
Jun 8, 2026
NEUTRAL 144 4/10
Director Arthur S. Kirsch filed a Form 144 notice of intent to sell 30,000 shares of Liquidia Corp c
Jun 5, 2026
BEARISH 144 6/10
Director Paul B. Manning filed a Form 144 on June 4, 2026, indicating intent to sell 200,000 shares
Jun 4, 2026
BEARISH 144 5/10
Venture capital firm Canaan VIII LP, a director of Liquidia Corp, filed a Form 144 on June 4, 2026,
Jun 4, 2026
NEUTRAL CLUSTER 3/10
Three Liquidia Corp insiders sold a total of ~$1.32M in open-market transactions over a one-week win
Jun 3, 2026
NEUTRAL CLUSTER 4/10
CEO Roger Jeffs sold 100,000 shares (~$6.1M) over four consecutive trading days, and director/10% ow
May 26, 2026
MIXED CLUSTER 5/10
LQDA CEO Roger Jeffs sold $5.84M worth of stock over four consecutive trading days (May 15-20) at pr
May 21, 2026
NEUTRAL CLUSTER 4/10
CEO Roger Jeffs and director Bloch Stephen sold a combined ~$11M in LQDA shares over the past week,
May 20, 2026
NEUTRAL CLUSTER 3/10
CEO Roger Jeffs and Director Stephen Bloch sold a combined $5.15M in open-market sales over a 5-day
May 15, 2026
BEARISH 144 5/10
Director Roger Jeffs filed a Form 144 to sell 100,000 shares of Liquidia Corp common stock, with an
May 14, 2026
BEARISH 144 6/10
Venture capital firm Canaan VIII LP, a director of Liquidia Corp, filed a Form 144 to sell 318,893 s
May 11, 2026
BULLISH 8-K 8/10
Liquidia Corp reported Q1 2026 results with YUTREPIA net product sales of $129.9M, net income of $52
May 11, 2026
BULLISH PRESS-RELEASE 7/10
Liquidia reported Q1 2026 revenue of $132.9M (driven by YUTREPIA sales of $129.9M) and net income of
May 11, 2026
NEUTRAL PRESS-RELEASE 2/10
Liquidia announced it will report Q1 2026 financial results and host a corporate update webcast on M
May 4, 2026
NEUTRAL DEFA14A 3/10
Liquidia Corp (LQDA) has filed a definitive proxy statement (DEFA14A) for its 2026 Annual Stockholde
Apr 24, 2026
BEARISH CLUSTER 7/10
Eight corporate insiders at Liquidia Corp, including the CEO, CFO, and multiple C-suite executives,
Apr 21, 2026
BEARISH 144 6/10
Roger Jeffs, a director and officer of Liquidia Corp, filed a Form 144 to report proposed sales of 1
Apr 17, 2026
Historical analyst distribution (last covering-analyst action Oct 2024): 93% buy across 14 analysts — 6 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.

Analyst Price Targets

Historical data — last covering-analyst action Oct 2024. No current recommendation available.
$66.13 mean target (Oct 2024)
$59.00 Low $75.00 High
MetricValue
Current Price$71.23
Target Low$59.00
Target Mean$66.13
Target Median$66.00
Target High$75.00
# Analysts8
Recommendation— (no recent coverage)

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$0.84 $0.77 $0.97 270.6% +57.7% 2↑ 1↓ $0.2B 1834.9% 5
Next Q
2026-09-30
$0.97 $0.41 $1.26 2515.0% +32.3% 2↑ 1↓ $0.2B 259.7% 5
Current FY
2026-12-31
$3.48 $2.36 $4.09 535.0% +35.0% 2↑ 1↓ $0.7B 357.9% 5
Next FY
2027-12-31
$5.57 $4.00 $7.16 60.1% +6.4% 2↑ 1↓ $1.2B 61.6% 5

Current Quarter EPS Revision History

TimepointEPS EstimateChange
Current$0.836
7d ago$0.836
30d ago$0.530+0.306
60d ago$0.530+0.306
90d ago$0.530+0.306
10 analyst firms have rated this stock: 1 upgrades, 1 downgrades, 6 initiations.

Historical Analyst Actions

DateAnalyst FirmActionPrevious RatingNew Rating
Oct 16, 2024 Scotiabank INITIATE Sector Outperform
Oct 3, 2024 LifeSci Capital INITIATE Outperform
Aug 23, 2024 HC Wainwright & Co. REITERATE Buy Buy
Aug 22, 2024 Needham REITERATE Buy Buy
Aug 20, 2024 BTIG MAINTAIN Buy Buy
Aug 20, 2024 B of A Securities MAINTAIN Buy Buy
Aug 20, 2024 HC Wainwright & Co. MAINTAIN Buy Buy
Aug 19, 2024 BTIG MAINTAIN Buy Buy
Aug 19, 2024 Raymond James UPGRADE Outperform Strong Buy
Aug 19, 2024 Needham REITERATE Buy Buy
Aug 16, 2024 Raymond James INITIATE Outperform
Aug 13, 2024 Needham REITERATE Buy Buy
Aug 8, 2024 Needham MAINTAIN Buy Buy
Jul 18, 2024 Needham REITERATE Buy Buy
Jul 10, 2024 HC Wainwright & Co. REITERATE Buy Buy
Jun 25, 2024 Oppenheimer INITIATE Perform
Jun 3, 2024 Needham REITERATE Buy Buy
May 15, 2024 HC Wainwright & Co. REITERATE Buy Buy
May 15, 2024 Needham REITERATE Buy Buy
Apr 10, 2024 Needham REITERATE Buy Buy
Apr 1, 2024 Needham REITERATE Buy Buy
Mar 14, 2024 HC Wainwright & Co. MAINTAIN Buy Buy
Mar 13, 2024 Needham MAINTAIN Buy Buy
Feb 21, 2024 Needham REITERATE Buy Buy
Jan 5, 2024 Needham MAINTAIN Buy Buy
Dec 21, 2023 Ladenburg Thalmann MAINTAIN Buy Buy
Dec 21, 2023 B of A Securities MAINTAIN Buy Buy
Dec 21, 2023 Wedbush REITERATE Underperform Underperform
Nov 8, 2023 Needham REITERATE Buy Buy
Aug 14, 2023 Wedbush REITERATE Underperform Underperform
Aug 11, 2023 HC Wainwright & Co. REITERATE Buy Buy
Aug 10, 2023 Needham REITERATE Buy Buy
Jul 31, 2023 Needham REITERATE Buy Buy
Jul 25, 2023 Needham REITERATE Buy Buy
Jun 30, 2023 Wedbush REITERATE Underperform
Jun 28, 2023 Needham MAINTAIN Buy Buy
May 9, 2023 Wedbush REITERATE Underperform
May 8, 2023 HC Wainwright & Co. REITERATE Buy
Apr 19, 2023 Needham REITERATE Buy
Mar 20, 2023 HC Wainwright & Co. REITERATE Buy
Mar 20, 2023 Wedbush REITERATE Underperform
Mar 17, 2023 Needham MAINTAIN Buy
Feb 3, 2023 Needham REITERATE Buy
Sep 2, 2022 Needham MAINTAIN Buy
Sep 1, 2022 Wedbush DOWNGRADE Neutral Underperform
Jul 22, 2022 Ladenburg Thalmann INITIATE Buy
Jul 20, 2022 BTIG MAINTAIN Buy
May 26, 2022 B of A Securities INITIATE Buy
Feb 3, 2022 HC Wainwright & Co. MAINTAIN Buy
Jan 10, 2022 Needham MAINTAIN Buy

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20266710093%
May 1, 20266710187%
Apr 1, 20266710187%
Mar 1, 20266710187%
Feb 1, 20266710187%
Jan 1, 20266710187%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

50°
Neutral
Bearish Neutral Bullish
1 mentions 0 bullish 0 bearish 1 time period

Reddit Sentiment History

DateMentionsSentimentBullishBearishThreads
Feb 27, 2026150° Neutral001

Recent Reddit Threads

r/investing Neutral 3mo ago
My quick review of the 5 year old "10x in 5-10 years" post
▲ 1 💬 0 ⚡ 0.0
Jun 11, 2026
short_volume
Short Volume: LQDA — 60.4% short (0.8M / 1.3M)
Short: 801,858 | Exempt: 774 | TRF Vol: 1,326,871 | Short Ratio: 60.4% | Off-exchange volume (dark pool + OTC)
Jun 10, 2026
short_volume
Short Volume: LQDA — 64.1% short (0.4M / 0.7M)
Short: 435,156 | Exempt: 1,941 | TRF Vol: 679,078 | Short Ratio: 64.1% | Off-exchange volume (dark pool + OTC)
Jun 9, 2026
short_volume
Short Volume: LQDA — 64.6% short (0.4M / 0.6M)
Short: 406,418 | Exempt: 871 | TRF Vol: 629,185 | Short Ratio: 64.6% | Off-exchange volume (dark pool + OTC)
Jun 8, 2026
other
Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index
Liquidia Corporation (Nasdaq: LQDA) will be added to the S&P SmallCap 600 Index, effective prior to the opening of trading June 22, 2026.
Jun 8, 2026
short_volume
Short Volume: LQDA — 62.7% short (0.8M / 1.3M)
Short: 815,130 | Exempt: 5,667 | TRF Vol: 1,299,225 | Short Ratio: 62.7% | Off-exchange volume (dark pool + OTC)
Jun 5, 2026
short_volume
Short Volume: LQDA — 60.8% short (0.5M / 0.8M)
Short: 470,142 | Exempt: 775 | TRF Vol: 772,700 | Short Ratio: 60.8% | Off-exchange volume (dark pool + OTC)
Jun 4, 2026
short_volume
Short Volume: LQDA — 65.1% short (1.4M / 2.2M)
Short: 1,411,297 | Exempt: 332 | TRF Vol: 2,169,511 | Short Ratio: 65.1% | Off-exchange volume (dark pool + OTC)
Jun 3, 2026
short_volume
Short Volume: LQDA — 56.6% short (0.3M / 0.6M)
Short: 318,021 | Exempt: 0 | TRF Vol: 561,483 | Short Ratio: 56.6% | Off-exchange volume (dark pool + OTC)
May 27, 2026
other
Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference
Liquidia CEO Roger Jeffs and COO/CFO Michael Kaseta will present at the Jefferies Global Healthcare Conference on June 3, 2026, at 12:45 p.m. ET.
May 14, 2026
short_interest
FTD: LQDA — 33,492 shares ($1.9M) failed to deliver
Settlement: 20260514, Price: $57.59, FTD Value: $1,928,804.28, LIQUIDIA CORPORATION COM (DE)
May 11, 2026
earnings
Liquidia Corporation Reports First Quarter 2026 Financial Results
Liquidia reports Q1 2026 results: $129.9M in YUTREPIA net product sales and third consecutive quarter of profitability.
May 11, 2026
earnings_calendar
LQDA Q1 2026 Earnings Before Market Open — 2026-05-11
May 8, 2026
short_volume
Short Volume: LQDA — 62.7% short (0.4M / 0.6M)
Short: 354,065 | Exempt: 0 | TRF Vol: 564,837 | Short Ratio: 62.7% | Off-exchange volume (dark pool + OTC)
May 7, 2026
earnings_calendar
LQDA Q1 2026 Earnings Before Market Open — 2026-05-07
May 6, 2026
other
Liquidia Corporation to Participate in Upcoming Investor Conferences
<p>MORRISVILLE, N.C., May 06, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compas